Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashChange in IntangiblesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet Income
Growth Metrics
Income Statement
Others
Ratios

CureVac (CVAC) Amortization (2021 - 2024)

Historic Amortization for CureVac (CVAC) over the last 4 years, with Q2 2024 value amounting to $2179.6.

  • CureVac's Amortization fell 105.65% to $2179.6 in Q2 2024 from the same period last year, while for Jun 2024 it was $2179.6, marking a year-over-year decrease of 105.65%. This contributed to the annual value of $2.4 billion for FY2020, which is 776.89% up from last year.
  • According to the latest figures from Q2 2024, CureVac's Amortization is $2179.6, which was down 105.65% from $2198.8 recorded in Q1 2024.
  • CureVac's Amortization's 5-year high stood at $2437.8 during Q1 2021, with a 5-year trough of $2171.4 in Q1 2023.
  • In the last 4 years, CureVac's Amortization had a median value of $2200.8 in 2023 and averaged $2243.3.
  • Its Amortization has fluctuated over the past 5 years, first crashed by 690.93% in 2022, then skyrocketed by 126.31% in 2024.
  • Quarter analysis of 4 years shows CureVac's Amortization stood at $2437.8 in 2021, then decreased by 6.91% to $2269.4 in 2022, then dropped by 2.93% to $2202.9 in 2023, then dropped by 1.06% to $2179.6 in 2024.
  • Its Amortization was $2179.6 in Q2 2024, compared to $2198.8 in Q1 2024 and $2202.9 in Q2 2023.